Fatima S. Abdulla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fatima S. Abdulla has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Afroz Ahmad
Department of Pharmacology, Faculty of Pharmacy, Integral University, Lucknow, India
1 shared publication - Akbar
Pharmaceutical Medicine, Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India
1 shared publication - Ashif Iqubal
Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, Delhi-110062, India
1 shared publication - Faheem Haider
Faculty of Pharmacy, Integral University, Lucknow, India
1 shared publication - Faheem Hyder Pottoo
Department of Pharmacology, College of Pharmacy, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia
1 shared publication Hamda Memon1
1 shared publication
Latest Publications
- Open Access
- 6 January 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (2) , 616
Neuroinflammation: A Potential Risk for Dementia
Dementia is a neurodegenerative condition that is considered a major factor contributing to cognitive decline that reduces independent function. Pathophysiological pathways are not well defined for neurodegenerative diseases such as dementia; however, published evidence has shown the role of numerous inflammatory processes in the brain contributing toward their pathology. Microglia of the central nervous system (CNS) are the principal components of the brain’s immune defence system and can detect harmful or external pathogens. When stimulated, the cells trigger neuroinflammatory responses by releasing proinflammatory chemokines, cytokines, reactive oxygen species, and nitrogen species in order to preserve the cell’s microenvironment. These proinflammatory markers include cytokines such as IL-1, IL-6, and TNFα chemokines such as CCR3 and CCL2 and CCR5. Microglial cells may produce a prolonged inflammatory response that, in some circumstances, is indicated in the promotion of neurodegenerative diseases. The present review is focused on the involvement of microglial cell activation throughout neurodegenerative conditions and the link between neuroinflammatory processes and dementia.
- 6 January 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (2) , 616
Open AccessNeuroinflammation: A Potential Risk for Dementia
Dementia is a neurodegenerative condition that is considered a major factor contributing to cognitive decline that reduces independent function. Pathophysiological pathways are not well defined for neurodegenerative diseases such as dementia; however, published evidence has shown the role of numerous inflammatory processes in the brain contributing toward their pathology. Microglia of the central nervous system (CNS) are the principal components of the brain’s immune defence system and can detect harmful or external pathogens. When stimulated, the cells trigger neuroinflammatory responses by releasing proinflammatory chemokines, cytokines, reactive oxygen species, and nitrogen species in order to preserve the cell’s microenvironment. These proinflammatory markers include cytokines such as IL-1, IL-6, and TNFα chemokines such as CCR3 and CCL2 and CCR5. Microglial cells may produce a prolonged inflammatory response that, in some circumstances, is indicated in the promotion of neurodegenerative diseases. The present review is focused on the involvement of microglial cell activation throughout neurodegenerative conditions and the link between neuroinflammatory processes and dementia.